Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150006/S009

CELT ACD VASCULAR CLOSURE DEVICE

Vasorum, Ltd. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONP150006/S009

What did the FDA approve?

FDA recorded an approval decision on 2026-10-30 for P150006/S009, a Special (Immediate Track) PMA supplement to Vasorum, Ltd.'s CELT ACD VASCULAR CLOSURE DEVICE. The supplement reason is listed as a labeling change covering indications, instructions, shelf life or tradename. The recorded statement describes changes to the Instructions for Use labeling for a limited number of CELT ACD PLUS 5F device lots.

This action amends labeling for specified lots of the CELT ACD PLUS 5F device; it is not a new approval of the whole system, and the source does not identify which labeling element changed, the affected lot numbers, or any clinical effect. The device is categorized as a hemostasis, vascular device under product code MGB in the Cardiovascular specialty. No supporting documents were included, so the revised labeling text and its scope remain unverified here.

FDA approval order statement

changes to the Instructions for Use labeling for a limited number of CELT ACD PLUS 5F device lots
Regulatory pathway
PMA supplement
Supplement type
Special (Immediate Track)
Clinical specialty
Cardiovascular
Decision date
Oct 30, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P150006/S009
Regulatory pathway
PMA supplement
Applicant
Vasorum, Ltd.
Product code
MGB
Decision code
APPR
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Applicant
Vasorum, Ltd.
Product code
MGB
FDA device class
3

For the original device and its historical approval scope, see PMA P150006. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150006 · Original PMA

    CELT ACD VASCULAR CLOSURE DEVICE

  2. P150006/S009 received

    Application receipt date recorded by FDA.

  3. P150006/S009 · FDA decision

    Special (Immediate Track)

Timeline entries are records held by MedtechLedger for P150006. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150006

Product / regulatory recordCompanyPathwayDecision dateSource
Vasorum, Ltd.PMA approvalJul 20, 2016FDA

Explore the linked device profile

Other records with product code MGB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Vasorum, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2012 Orchard Ave., Citywest Business Campus, Dublin, 24

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records